Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Immune responses following stereotactic body radiotherapy for stage I primary lung cancer.

Maehata Y, Onishi H, Kuriyama K, Aoki S, Araya M, Saito R, Tominaga L, Oguri M, Araki T.

Biomed Res Int. 2013;2013:731346. doi: 10.1155/2013/731346.

2.

Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.

Grzegorzewska AE, Leander M.

Adv Perit Dial. 2001;17:10-4.

PMID:
11510253
3.

[Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].

Yan X, Zhao X, Jiao S, Sun S, Wu L, Wu Z.

Zhongguo Fei Ai Za Zhi. 2012 Mar;15(3):164-71. doi: 10.3779/j.issn.1009-3419.2012.03.06. Chinese.

4.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55.

PMID:
12459356
5.

Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.

Dworzecki T, Idasiak A, Syguła D, Dworzecka U, Suwiński R.

Neoplasma. 2012;59(1):114-20.

PMID:
22103905
6.

The open window of susceptibility to infection after acute exercise in healthy young male elite athletes.

Kakanis MW, Peake J, Brenu EW, Simmonds M, Gray B, Hooper SL, Marshall-Gradisnik SM.

Exerc Immunol Rev. 2010;16:119-37.

7.

Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.

Hamamoto Y, Kataoka M, Yamashita M, Shinkai T, Kubo Y, Sugawara Y, Inoue T, Sakai S, Aono S, Takahashi T, Semba T, Uwatsu K.

Jpn J Clin Oncol. 2010 Feb;40(2):125-9. doi: 10.1093/jjco/hyp129.

PMID:
19825814
8.

[Circulating lymphocyte subsets in patients with lung cancer and their prognostic value].

Luo J, Ling Z, Mao W.

Zhongguo Fei Ai Za Zhi. 2011 Aug;14(8):669-73. doi: 10.3779/j.issn.1009-3419.2011.08.06. Chinese.

9.
10.

CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.

Karagöz B, Bilgi O, Gümüs M, Erikçi AA, Sayan O, Türken O, Kandemir EG, Oztürk A, Yaylaci M.

Med Oncol. 2010 Mar;27(1):29-33. doi: 10.1007/s12032-008-9165-9.

PMID:
19148592
11.

Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751.

PMID:
20638194
12.

Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.

Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N.

Clin Lung Cancer. 2008 Jul;9(4):217-21. doi: 10.3816/CLC.2008.n.032.

PMID:
18650169
13.

Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.

Mazzoccoli G, Balzanelli M, Giuliani A, De Cata A, La Viola M, Carella AM, Bianco G, Tarquini R.

In Vivo. 1999 May-Jun;13(3):205-9.

PMID:
10459492
14.

Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients.

Nakayama Y, Makino S, Fukuda Y, Min KY, Ikemoto T, Shimizu A, Ohsawa N.

Intern Med. 1995 Oct;34(10):959-65.

15.

Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.

Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao Z, Komaki R, Chang JY.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1387-93. doi: 10.1016/j.ijrobp.2009.09.070.

16.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664
17.
18.

Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Veenstra H, Baumann R, Carroll NM, Lukey PT, Kidd M, Beyers N, Bolliger CT, van Helden PD, Walzl G.

Clin Exp Immunol. 2006 Aug;145(2):252-60.

19.

Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.

Rosen LR, Fischer-Valuck BW, Katz SR, Durci M, Wu HT, Syh J, Syh J, Patel B.

Tumori. 2014 Jan-Feb;100(1):42-8. doi: 10.1700/1430.15814.

PMID:
24675490
20.

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

Dunlap NE, Larner JM, Read PW, Kozower BD, Lau CL, Sheng K, Jones DR.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9. doi: 10.1016/j.jtcvs.2010.01.046.

Supplemental Content

Support Center